Oliveira, A. I. S. (2022). Evaluation of 11-dehydro-thromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure and cardiogenic shock.
Chicago Style (17th ed.) CitationOliveira, Ana Isabel Sousa. Evaluation of 11-dehydro-thromboxane B2 as a Biomarker of Severity and Putative Therapeutic Target in Human Acute Heart Failure and Cardiogenic Shock. 2022.
MLA (8th ed.) CitationOliveira, Ana Isabel Sousa. Evaluation of 11-dehydro-thromboxane B2 as a Biomarker of Severity and Putative Therapeutic Target in Human Acute Heart Failure and Cardiogenic Shock. 2022.
Warning: These citations may not always be 100% accurate.